-
Y-mAbs Therapeutics' (YMAB) "Outperform" Rating Reaffirmed at Wedbush
来源: Buzz FX / 04 3月 2025 18:51:14 America/New_York
Y-mAbs Therapeutics' (YMAB) "Outperform" Rating Reaffirmed at Wedbush Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Y-mAbs Therapeutics ( NASDAQ:YMAB - Get Free Report ) 's stock had its "outperform" rating reaffirmed
Read more...